X6: A Novel Antibody for Potential Use in Gluten Quantification

Area of Science:

• Food Science
• Immunology
• Analytical Chemistry

Background:

• Celiac disease is triggered by gliadin, a gluten fraction, necessitating strict gluten-free diets.
• Accurate gluten detection in food is vital for managing celiac disease.
• Enzyme-Linked Immunosorbent Assay (ELISA) is a common method for gluten quantification, requiring specific high-affinity antibodies.

Purpose of the Study:

• To characterize a novel anti-gliadin antibody, designated X6.
• To identify the specific epitope recognized by antibody X6.
• To evaluate the performance of X6 in gluten detection assays.

Main Methods:

• Immunoblotting was used to determine antibody specificity against various cereal prolamins.
• ELISA was employed to assess the quantitative correlation of X6 with established gluten detection standards (R5 and G12).
• Qualitative assessment compared the performance of X6 with R5 and G12.

Main Results:

• Antibody X6 recognizes the QXQPFPXP epitope, binding specifically to cereal prolamins implicated in celiac disease.
• X6 demonstrated recognition of wheat, barley, and rye proteins, including α-gliadin homologs.
• X6 showed less reactivity to avenin and did not recognize proteins from Zea mays or Setaria italica.
• X6-based ELISA showed high correlation with R5 and G12 standards for quantitative gluten assessment (Pearson's R = 0.86 and 0.87).
• Qualitative analysis indicated no significant differences between X6, R5, and G12.

Conclusions:

• The novel anti-gliadin antibody X6 exhibits high specificity and affinity for celiac-relevant gliadin epitopes.
• X6 is a promising candidate for gluten detection assays, correlating well with current industry standards.
• This antibody can contribute to improved gluten control in food products for celiac disease management.